期刊文献+

阿维链霉菌发酵培养基的优化 被引量:1

Medium Optimization of Streptomyces avermitilis for Fermentation
下载PDF
导出
摘要 通过优化发酵过程中培养基的组成使得阿维链霉菌的发酵单位及有效组分Bla含量提高。采用单因子试验法及均匀设计试验法分析各种营养成分及其配比对阿维链霉菌Co39-15发酵单位和有效组分Bla含量的影响。获得最佳的种子培养基和发酵培养基配方,发酵单位及有效组分Bla含量比原来的发酵水平分别提高了20%~30%、8%~10%。利用单因子试验法及均匀设计试验法对抗生素的发酵培养基进行优化,是一种快速、效果显著的方法。 In order to increase fermentation unit and the content of effective component of B1 a by Streptomyces avermitilis (SA) the ingredients of medium during the fermentation were optimized using single factor experiment and uniform design to analyze the effects of various nutrition ingredients and their proportions on the fermentation unit and the content of effective component of B1 a by SA Co39-15. With the optimized strain seed culture medium and fermentation medium the fermentation unit and the content of effective component of B1 a increased by 20% - 30% and 8% - 10% respectively as compared with the original fermentation level. Therefore, using single factor experimentation and uniform design experimentation to optimize the fermentation medium for antibiotics production is a kind of rapid and highly effective methods.
出处 《微生物学杂志》 CAS CSCD 2008年第2期15-20,共6页 Journal of Microbiology
基金 辽宁省企业博士后项目(辽博函2006-4) 中国博士后项目(20070410356)
关键词 阿维链霉菌 单因子试验 均匀设计试验 Streptomyces avermitilis single factor experimentation uniform design experimentation
  • 相关文献

参考文献7

  • 1Burg RW, Miller BM, Baker EE, et al. Avermeetins, new family of potent anthelmintic agents. Producing organism and fermentation [ J ]. Antimicrobial Agents and Chemotherapy, 1979, 15(3) :361-367.
  • 2扈洪波,朱蓓蕾,李俊锁.阿维菌素类药物的研究进展[J].畜牧兽医学报,2000,31(6):520-529. 被引量:80
  • 3霍长河,曹海峰,刘成琴,许平,王成迎.Co^(60)照射在链霉素产生菌选育中的应用[J].中国抗生素杂志,2005,30(3):169-170. 被引量:3
  • 4王晓伟,何建勇,白秀峰.Strep tomyces averm it il is E107异常代谢产物的研究[J].中国抗生素杂志,2001,26(6):429-431. 被引量:7
  • 5曾绍钧.均匀设计及其应用[M].北京:中国医药科技出版社,2005,122-124.
  • 6Omura S, Ikeda H, Ishikawa J, et al. Genome sequence of an industrial microorganism Streptomyees avermitilis: deducing the ability of producing secondary metabolites [ J ]. Proceedings of the National Academy of Sciences of the United States of America,2001, 98:12 215-12 220.
  • 7Yoon YJ, Kim ES, Hwang YS, et al. Avermectin: biochemical and molecular basis of its biosynthesis and regulation[ J]. Applied Microbiology and Biotechnology, 2004, 63: 626-634.

二级参考文献28

  • 1[1] Goudie A C,Evans N A,Gration K A F,et al.Doramectin-a potent novel endectocid[J].Veterinary Parasitology,1993,49,5~15.
  • 2[2] Shoop W L,et al.Eprinomectin:a novel avermectin for use as a topical endectocide for cattle[J],International Journal Parasitology,1996,26(11):1237~1242.
  • 3[3] Mckellar Q A, Benchaoui H A.Avermectins and milbermycins[J].Journal of Veterinary Pharmacology and Therapeutics.,1996,19:331~351.
  • 4[4] Shoop W L,Morzik H,Fisher M H.Structure and activity of avermectins and milbemycins in animal health[J].Veterinary Parasitology,1995,59,139~156.
  • 5[6] Mrozik H,Eskola P,Reynolds G F,et al.Photoisomers of avermectins[J].Journal of Organic Chemistry,1988,53,1820~1823.
  • 6[7] Mckellar Q A.Developments in pharmackinetics and pharmacodynamics of anthelmintic drugs[J].Journal of Veterinary Pharmacology and Therapeutics.,1997,20(suppl.1):10~11.
  • 7[8] Payne L d,et al.HPLC~Fluorescence method for the determination of eprinomectin marker residue in edible bovine tissue[J].Journal of Agriculture and Food Chemistry,1997,45,3501~3505.
  • 8[10] Halley B A,Nessel R J,Lu A Y H.Environmental aspects of ivermectin usage in livestock:general consideration[M].In.Ed.Campbell,W.C.Springer~Verlag,New York.1989,162~172.
  • 9[11] Bogan J A,Mckellar Q A.The pharmacodynamics of ivermectin in sheep and cattle[J].Journal of Veterinary Pharmacology and Therapeutics,1988,11,260~268.
  • 10[14] Campbell W C,Benz G W.Ivermectin:a review of efficacy and safety[J].Journal of Veterinary Pharmacology and Therapeutics,1984,7,1~16.

共引文献85

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部